Long-term outcome of Guillain-Barré syndrome in children

Joyce Roodbol1, Marie-Claire Y de Wit, Femke K Aarsen

  • 1Department of Pediatric Neurology, Erasmus MC and Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Neurology, Erasmus MC and Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Immunology, Erasmus MC and Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Insights

Guillain-Barré syndrome (GBS) often leads to long-term issues in children, including persistent symptoms and psychosocial challenges impacting daily life. Many children experience residual complaints affecting their quality of life and school careers.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Longitudinal Cohort Studies

Background:

  • Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting the peripheral nervous system.
  • Understanding the long-term consequences of GBS in pediatric populations is crucial for comprehensive care.

Purpose of the Study:

  • To evaluate the long-term clinical outcomes and psychosocial impact of GBS in children.
  • To identify persistent symptoms, neurological deficits, and quality of life changes in pediatric GBS survivors.

Main Methods:

  • Observational, cross-sectional cohort study of children diagnosed with GBS (0-18 years) between 1987-2009.
  • Data collection involved structured interviews, questionnaires, and neurologic examinations.
  • Assessed current clinical condition, including symptoms, deficits, disabilities, behavior, and quality of life.

Main Results:

  • 65% of participants reported residual complaints, such as paresthesias, gait unsteadiness, pain, and fatigue.
  • 4 patients had severe neurological deficits (e.g., facial diplegia, limb weakness); 2 experienced GBS recurrence.
  • 26% of patients experienced a negative impact on their school careers; behavioral problems were noted.

Conclusions:

  • While most children achieve good neurological recovery post-GBS, many face persistent long-term symptoms.
  • These residual symptoms can lead to psychosocial issues, affecting daily life participation.
  • Long-term follow-up is essential to manage GBS sequelae in children.

Related Concept Videos

Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
51
Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
51.5K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.7K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49